-
Discriminative Kernel Convolution Network for Multi-Label Ophthalmic Disease Detection on Imbalanced Fundus Image Dataset
Authors:
Amit Bhati,
Neha Gour,
Pritee Khanna,
Aparajita Ojha
Abstract:
It is feasible to recognize the presence and seriousness of eye disease by investigating the progressions in retinal biological structure. Fundus examination is a diagnostic procedure to examine the biological structure and anomaly of the eye. Ophthalmic diseases like glaucoma, diabetic retinopathy, and cataract are the main reason for visual impairment around the world. Ocular Disease Intelligent…
▽ More
It is feasible to recognize the presence and seriousness of eye disease by investigating the progressions in retinal biological structure. Fundus examination is a diagnostic procedure to examine the biological structure and anomaly of the eye. Ophthalmic diseases like glaucoma, diabetic retinopathy, and cataract are the main reason for visual impairment around the world. Ocular Disease Intelligent Recognition (ODIR-5K) is a benchmark structured fundus image dataset utilized by researchers for multi-label multi-disease classification of fundus images. This work presents a discriminative kernel convolution network (DKCNet), which explores discriminative region-wise features without adding extra computational cost. DKCNet is composed of an attention block followed by a squeeze and excitation (SE) block. The attention block takes features from the backbone network and generates discriminative feature attention maps. The SE block takes the discriminative feature maps and improves channel interdependencies. Better performance of DKCNet is observed with InceptionResnet backbone network for multi-label classification of ODIR-5K fundus images with 96.08 AUC, 94.28 F1-score and 0.81 kappa score. The proposed method splits the common target label for an eye pair based on the diagnostic keyword. Based on these labels oversampling and undersampling is done to resolve class imbalance. To check the biasness of proposed model towards training data, the model trained on ODIR dataset is tested on three publicly available benchmark datasets. It is found to give good performance on completely unseen fundus images also.
△ Less
Submitted 16 July, 2022;
originally announced July 2022.
-
On the Age of Information of a Queuing System with Heterogeneous Servers
Authors:
Anhad Bhati,
Sibi Raj B. Pillai,
Rahul Vaze
Abstract:
An optimal control problem with heterogeneous servers to minimize the average age of information (AoI) is considered. Each server maintains a separate queue, and each packet arriving to the system is randomly routed to one of the servers. Assuming Poisson arrivals and exponentially distributed service times, we first derive an exact expression of the average AoI for two heterogeneous servers. Next…
▽ More
An optimal control problem with heterogeneous servers to minimize the average age of information (AoI) is considered. Each server maintains a separate queue, and each packet arriving to the system is randomly routed to one of the servers. Assuming Poisson arrivals and exponentially distributed service times, we first derive an exact expression of the average AoI for two heterogeneous servers. Next, to solve for the optimal average AoI, a close approximation is derived, called the approximate AoI, this is shown to be useful for multi-server systems as well. We show that for the optimal approximate AoI, server utilization (ratio of arrival rate and service rate) for each server should be same as the optimal server utilization with a single server queue. For two identical servers, it is shown that the average AoI is approximately 5/8 times the average AoI of a single server. Furthermore, the average AoI is shown to decrease considerably with the addition of more servers to the system.
△ Less
Submitted 14 September, 2021; v1 submitted 13 September, 2021;
originally announced September 2021.
-
Pandemic Drugs at Pandemic Speed: Infrastructure for Accelerating COVID-19 Drug Discovery with Hybrid Machine Learning- and Physics-based Simulations on High Performance Computers
Authors:
Agastya P. Bhati,
Shunzhou Wan,
Dario Alfè,
Austin R. Clyde,
Mathis Bode,
Li Tan,
Mikhail Titov,
Andre Merzky,
Matteo Turilli,
Shantenu Jha,
Roger R. Highfield,
Walter Rocchia,
Nicola Scafuri,
Sauro Succi,
Dieter Kranzlmüller,
Gerald Mathias,
David Wifling,
Yann Donon,
Alberto Di Meglio,
Sofia Vallecorsa,
Heng Ma,
Anda Trifan,
Arvind Ramanathan,
Tom Brettin,
Alexander Partin
, et al. (4 additional authors not shown)
Abstract:
The race to meet the challenges of the global pandemic has served as a reminder that the existing drug discovery process is expensive, inefficient and slow. There is a major bottleneck screening the vast number of potential small molecules to shortlist lead compounds for antiviral drug development. New opportunities to accelerate drug discovery lie at the interface between machine learning methods…
▽ More
The race to meet the challenges of the global pandemic has served as a reminder that the existing drug discovery process is expensive, inefficient and slow. There is a major bottleneck screening the vast number of potential small molecules to shortlist lead compounds for antiviral drug development. New opportunities to accelerate drug discovery lie at the interface between machine learning methods, in this case developed for linear accelerators, and physics-based methods. The two in silico methods, each have their own advantages and limitations which, interestingly, complement each other. Here, we present an innovative infrastructural development that combines both approaches to accelerate drug discovery. The scale of the potential resulting workflow is such that it is dependent on supercomputing to achieve extremely high throughput. We have demonstrated the viability of this workflow for the study of inhibitors for four COVID-19 target proteins and our ability to perform the required large-scale calculations to identify lead antiviral compounds through repurposing on a variety of supercomputers.
△ Less
Submitted 4 September, 2021; v1 submitted 4 March, 2021;
originally announced March 2021.
-
Scalable HPC and AI Infrastructure for COVID-19 Therapeutics
Authors:
Hyungro Lee,
Andre Merzky,
Li Tan,
Mikhail Titov,
Matteo Turilli,
Dario Alfe,
Agastya Bhati,
Alex Brace,
Austin Clyde,
Peter Coveney,
Heng Ma,
Arvind Ramanathan,
Rick Stevens,
Anda Trifan,
Hubertus Van Dam,
Shunzhou Wan,
Sean Wilkinson,
Shantenu Jha
Abstract:
COVID-19 has claimed more 1 million lives and resulted in over 40 million infections. There is an urgent need to identify drugs that can inhibit SARS-CoV-2. In response, the DOE recently established the Medical Therapeutics project as part of the National Virtual Biotechnology Laboratory, and tasked it with creating the computational infrastructure and methods necessary to advance therapeutics dev…
▽ More
COVID-19 has claimed more 1 million lives and resulted in over 40 million infections. There is an urgent need to identify drugs that can inhibit SARS-CoV-2. In response, the DOE recently established the Medical Therapeutics project as part of the National Virtual Biotechnology Laboratory, and tasked it with creating the computational infrastructure and methods necessary to advance therapeutics development. We discuss innovations in computational infrastructure and methods that are accelerating and advancing drug design. Specifically, we describe several methods that integrate artificial intelligence and simulation-based approaches, and the design of computational infrastructure to support these methods at scale. We discuss their implementation and characterize their performance, and highlight science advances that these capabilities have enabled.
△ Less
Submitted 20 October, 2020;
originally announced October 2020.
-
IMPECCABLE: Integrated Modeling PipelinE for COVID Cure by Assessing Better LEads
Authors:
Aymen Al Saadi,
Dario Alfe,
Yadu Babuji,
Agastya Bhati,
Ben Blaiszik,
Thomas Brettin,
Kyle Chard,
Ryan Chard,
Peter Coveney,
Anda Trifan,
Alex Brace,
Austin Clyde,
Ian Foster,
Tom Gibbs,
Shantenu Jha,
Kristopher Keipert,
Thorsten Kurth,
Dieter Kranzlmüller,
Hyungro Lee,
Zhuozhao Li,
Heng Ma,
Andre Merzky,
Gerald Mathias,
Alexander Partin,
Junqi Yin
, et al. (11 additional authors not shown)
Abstract:
The drug discovery process currently employed in the pharmaceutical industry typically requires about 10 years and $2-3 billion to deliver one new drug. This is both too expensive and too slow, especially in emergencies like the COVID-19 pandemic. In silicomethodologies need to be improved to better select lead compounds that can proceed to later stages of the drug discovery protocol accelerating…
▽ More
The drug discovery process currently employed in the pharmaceutical industry typically requires about 10 years and $2-3 billion to deliver one new drug. This is both too expensive and too slow, especially in emergencies like the COVID-19 pandemic. In silicomethodologies need to be improved to better select lead compounds that can proceed to later stages of the drug discovery protocol accelerating the entire process. No single methodological approach can achieve the necessary accuracy with required efficiency. Here we describe multiple algorithmic innovations to overcome this fundamental limitation, development and deployment of computational infrastructure at scale integrates multiple artificial intelligence and simulation-based approaches. Three measures of performance are:(i) throughput, the number of ligands per unit time; (ii) scientific performance, the number of effective ligands sampled per unit time and (iii) peak performance, in flop/s. The capabilities outlined here have been used in production for several months as the workhorse of the computational infrastructure to support the capabilities of the US-DOE National Virtual Biotechnology Laboratory in combination with resources from the EU Centre of Excellence in Computational Biomedicine.
△ Less
Submitted 13 October, 2020;
originally announced October 2020.
-
FabSim: facilitating computational research through automation on large-scale and distributed e-infrastructures
Authors:
Derek Groen,
Agastya Bhati,
James Suter,
James Hetherington,
Stefan Zasada,
Peter Coveney
Abstract:
We present FabSim, a toolkit developed to simplify a range of computational tasks for researchers in diverse disciplines. FabSim is flexible, adaptable, and allows users to perform a wide range of tasks with ease. It also provides a systematic way to automate the use of resourcess, including HPC and distributed resources, and to make tasks easier to repeat by recording contextual information. To d…
▽ More
We present FabSim, a toolkit developed to simplify a range of computational tasks for researchers in diverse disciplines. FabSim is flexible, adaptable, and allows users to perform a wide range of tasks with ease. It also provides a systematic way to automate the use of resourcess, including HPC and distributed resources, and to make tasks easier to repeat by recording contextual information. To demonstrate this, we present three use cases where FabSim has enhanced our research productivity. These include simulating cerebrovascular bloodflow, modelling clay-polymer nanocomposites across multiple scales, and calculating ligand-protein binding affinities.
△ Less
Submitted 7 December, 2015;
originally announced December 2015.
